—
Apheresis system assists in the collection and separation of blood components for donation. In addition, this system can perform removal or exchange of blood components for therapeutic procedures. The American National Red Cross offers various therapeutic apheresis services across the U.S. that include plasmapheresis, photopheresis, LDL apheresis, and stem cell harvest. In addition, the center has employed qualified and specialized staff for apheresis procedures while maintaining the accessibility and availability regarding the same. Increase in the number of such blood centers across the globe significantly drives the growth of the apheresis market.
The global apheresis market was valued at $2,560.4 million in 2016, and is projected to reach $4,200.6 million by 2023, growing at a CAGR of 7.3% from 2017 to 2023. The disposable & reagents segment accounted for four-ninths of the total market share in 2016.
Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/2855
In addition, rise in government initiatives that promote blood donations in the developing countries such as China and India propels the market growth. For instance, Twitter has recently launched a social initiative called BloodMatters in India on March 2018. Twitter has collaborated with the voluntary blood donation helpline named Blood Donors. Moreover, increase in number of blood donations was observed in China in 2014, which led to increase in the number of blood centers in the country. Such circumstances positively impact the market growth.
The centrifugation method generated the highest revenue in 2016, and is expected to maintain this dominance throughout the forecast period. This is attributed to the fact that centrifugation is considered to be a standard method for apheresis, and is highly favored by the blood industry across the globe. However, the membrane separation segment is expected to register the highest growth rate during the forecast period, owing to rise in demand for membrane separation apheresis, as it prevents the need for replacement fluids by not depleting the blood coagulation factors.
Based on procedure, the market is divided into donor/automated apheresis and therapeutic apheresis. Donor/automated apheresis is anticipated to dominate the global market throughout the forecast period, due to increase in gap between blood supply and blood products, which facilitate the need for using apheresis machines. Moreover, rise in apheresis procedures across several specialties such as hematology, neurology, and oncology has contributed towards the robust growth displayed by this segment. The therapeutic apheresis is expected to grow at the highest rate from 2017 to 2023.
Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/2855
Asia-Pacific is expected to witness the highest growth rate throughout the forecast period, due to its high population base, upsurge in disposable income, and rise in patient awareness towards blood donation. In addition, increase in incidence of dengue across countries in the Asia-Pacific region is the key contributor for the market growth in the region.
The Major Key Players Are:
Haemonetics Corporation
Fresenius Kabi
Terumo BCT, Inc.
Asahi Kasei Medical Co., Ltd.
HemaCare Corporation
Kaneka Corporation
Kawasumi Laboratories Inc.
Cerus Corporation
B. Braun Melsungen AG
Nikkiso Co., Ltd.
The Other Prominent Players Are:
Grifols International SA
Baxter International Inc.
CSL Behring
Immucor, Becto
Dickinson & Co.
Abbott Laboratories
Medicap
Bioelettronica.
Access Full Report @ https://www.alliedmarketresearch.com/apheresis-market
Key Findings of the Apheresis Market:
The platelets (plateletpheresis) segment is expected to register the highest growth rate from 2017 to 2023.
Blood centers accounted for maximum revenue in 2016, and is anticipated to maintain this trend throughout the forecast period.
North America dominated the global apheresis market, accounting for maximum share in 2016, and is expected to retain the same trend during the forecast period.
Intermittent flow centrifugation segment dominated the centrifugation apheresis market in 2016 and is expected to maintain this trend during the forecast period.
Photopheresis is estimated to exhibit the highest CAGR of 9.3% from 2017 to 2023 in the therapeutic apheresis market.
Similar Reports:
Catheters Market: Global Opportunity Analysis and Industry Forecast, 2021–2030
Stroke Management Market: Global Opportunity Analysis and Industry Forecast, 2021–2030
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact Info:
Name: David Correa
Email: Send Email
Organization: Allied Market Research
Address: 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States
Phone: +1-800-792-5285
Website: https://www.alliedmarketresearch.com/
Release ID: 89031612
Google
RSS